SCHEMBL6316540

SCHEMBL6316540

CCCCNC(=O)c1c(-c2ccsc2)noc1NC(=O)c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.48
NAAA Q02083 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
HDAC6 Q9UBN7 4/20 0.42
HDAC1 Q13547 4/20 0.42
HDAC3 O15379 4/20 0.42
NCOR2 Q9Y618 3/20 0.42
HDAC2 Q92769 2/20 0.42
HDAC4 P56524 1/20 0.42
HDAC5 Q9UQL6 1/20 0.42
BCL2 P10415 1/20 0.42
MCL1 Q07820 1/20 0.42
KIT P10721 1/20 0.41
FLT1 P17948 1/20 0.41
KDR P35968 1/20 0.41
SMN1; SMN2 Q16637 3/20 0.40
MEN1 O00255 1/20 0.40
POLB P06746 1/20 0.40
KMT2A Q03164 1/20 0.40
DRD2 P14416 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6318223 0.89 GAA (0.48) GAAL3MBTL1HDAC6HDAC1HDAC3
SCHEMBL6318603 0.87 L3MBTL1 (0.47) GAAL3MBTL1HDAC6HDAC1HDAC3
SCHEMBL6324057 0.87 L3MBTL1 (0.47) GAAL3MBTL1HDAC6HDAC1HDAC3
SCHEMBL6316801 0.86 ADORA1 (0.47) GAAL3MBTL1HDAC6HDAC1HDAC3
SCHEMBL6319331 0.85 HDAC3 (0.47) GAAL3MBTL1HDAC3KITFLT1
SCHEMBL6318154 0.85 GAA (0.46) GAAL3MBTL1HDAC6HDAC1HDAC3
SCHEMBL6318504 0.84 GAA (0.42) GAAL3MBTL1HDAC6HDAC1HDAC3
SCHEMBL6317516 0.83 L3MBTL1 (0.45) GAAL3MBTL1HDAC6HDAC1HDAC3
SCHEMBL6322113 0.83 GAA (0.42) GAAL3MBTL1HDAC6HDAC1HDAC3
SCHEMBL6322968 0.83 KIT (0.47) KITFLT1KDRSMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050059657-A1 Aminoisoxazole derivatives active as kinase inhibitors PFIZER ITALIA S.R.L. (IT) 2005-03-17 US claimed
EP-1435948-A1 AMINOISOXAZOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS Pharmacia Italia S.p.A. (IT) 2004-07-14 EP claimed
WO-2003013517-A1 AMINOISOXAZOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS PHARMACIA ITALIA S.P.A. (IT) 2003-02-20 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050059657-A1 Aminoisoxazole derivatives active as kinase inhibitors MAP3K9, MAP3K19, MAP4K2 GAA 789/4885NAAA 1340/4885L3MBTL1 4176/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.